StemCell Technologies

570 west 7th avenue,

Vancouver BC,

V5Z 1B3,

Canada

Tel: 1-800-667-0322
Fax:
Email Us

Print Email to a friend

StemCell Technologies is the recognized leader in the research and development of hematopoietic stem cell progenitor assays and related products, and our experience and expertise in hemotoxicity and immunotoxicity is now available through our Contract Assay Service.  Combining StemCell Technologies' industry standard reagents and a scientific team of experts in hematopoiesis and stem cell biology, we are proud to assist organizations in drug development, agrochemical production and environmental toxicant testing

StemCell Technologies is actively working with companies offering extensive skills and experience to define and execute specialized services that address hematopoietic and non-hematopoietic preclinical and phase I requirements.  Our service applications include toxicology studies, blood-cell/bone marrow modulating studies, phenotypic characterization, validation studies of drug candidates and in vivo testing services, all supported by a highly skilled team in our Contract Services Division.  All assays are performed in our level 2 laboratory following GLP protocols. We will analyze and interpret resulting data and provide you with a complete written report suitable for FDA Submission. We adhere to the highest professional standards and guarantee you complete confidentiality.

Further Information: http://www.contractassay.com



Related Products

STEMCELL Technologies Introduces AggreWell™400 for Standardized Embryonic Stem Cell and Induced Pluripotent Stem Cell Research
STEMCELL Technologies, a leader in specialty cell culture media, cell separation products and ancillary reagents for stem cell research, today announced the release of the AggreWell™400 plates, a revolutionary tool for researchers using embryonic and induced pluripotent stem cells (ESC and iPSC).



Related news from our archive

STEMCELL Technologies Inc. Announces Direct Distribution to Spain
According to Company, customers in Spain will have immediate access to in-house scientists and its technical support team.

STEMCELL Technologies Launches Direct Distribution to Singapore
STEMCELL announces the opening of a new sales and distribution office in Singapore, effective January 12th, 2009.